Edward M. Rudnic, President and CEO at MiddleBrook Pharmaceuticals, Inc. (MBRK), sold 12,600 shares at $1.46 ($18K) on 2007-10-18, disclosed to the SEC on 2007-10-18.
Scheduled sale ($18k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 1,800 | $3K | 14.2% |
| 2 | $1.41 | 9,801 | $14K | 77.8% |
| 3 | $1.42 | 499 | $709 | 4.0% |
| 4 | $1.44 | 100 | $144 | 0.8% |
| 5 | $1.45 | 229 | $332 | 1.9% |
| 6 | $1.46 | 171 |
| $250 |
| 1.4% |
| Total | $1.41 avg | 12,600 | $18K | 100% |
| Filing → |
| MBRK | SELL | 2007-11-23 | $20K | — | Filing → |
| MBRK | SELL | 2007-10-17 | $42K | — | Filing → |
| MBRK | SELL | 2007-09-19 | $90K | — | Filing → |